Potential mechanisms of enteric cytoprotection by probiotics: Lessons from cultured human intestinal cells

Probiotic Bacteria and Enteric Infections: Cytoprotection by Probiotic Bacteria

Volumn , Issue , 2011, Pages 375-397

  Moal, Vanessa Liévin Le ^a   Servin, Alain L ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Bifidobacterium; Intestinal cells; Intestinal functions; Lactobacillus; Probiotics

Indexed keywords

EID: 84900662933     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-0386-5_16     Document Type: Chapter

References (145)

1. Abreu MT, Fukata M, Arditi M (2005) TLR signaling in the gut in health and disease. J Immunol 174:4453-4460
2. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499-511
3. Augeron C, Voisin T, Maoret JJ, Berthon B, Laburthe M, Laboisse CL (1992) Neurotensin and neuromedin N stimulate mucin output from human goblet cells (Cl.16E) via neurotensin receptors. Am J Physiol 262:G470-G476
4. Ayabe T, Ashida T, Kohgo Y, Kono T (2004) The role of Paneth cells and their antimicrobial peptides in innate host defense. Trends Microbiol 12:394-398
5. Bai AP, Ouyang Q, Zhang W, Wang CH, Li SF (2004) Probiotics inhibit TNF-alpha-induced interleukin-8 secretion of HT29 cells. World J Gastroenterol 10:455-457
6. Banerjee P, Merkel GJ, Bhunia AK (2009) Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog 1:8
7. Baricault L, Denariaz G, Houri JJ, Bouley C, Sapin C, Trugnan G (1995) Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 16:245-252
8. Blandino G, Fazio D, Di Marco R (2008) Probiotics: overview of microbiological and immunological characteristics. Expert Rev Anti Infect Ther 6:497-508
9. Boirivant M, Strober W (2007) The mechanism of action of probiotics. Curr Opin Gastroenterol 23:679-692
10. Borthakur A et al (2008) The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells. J Nutr 138:1355-1359
11. Caballero-Franco C, Keller K, De Simone C, Chadee K (2007) The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292:G315-G322
12. Camp JG, Kanther M, Semova I, Rawls JF (2009) Patterns and scales in gastrointestinal microbial ecology. Gastroenterology 136:1989-2002
13. Candela M et al (2008) Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int J Food Microbiol 125:286-292
14. Cario E, Podolsky DK (2005) Intestinal epithelial TOLLerance versus in TOLLerance of commensals. Mol Immunol 42:887-893
15. Chantret I et al (1994) Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J Cell Sci 107(Pt 1):213-225
16. Clark MA, Jepson MA (2003) Intestinal M cells and their role in bacterial infection. Int J Med Microbiol 293:17-39
17. Coburn B, Grassl GA, Finlay BB (2007) Salmonella, the host and disease: a brief review. Immunol Cell Biol 85:112-118
18. Coconnier MH, Liévin V, Lorrot M, Servin AL (2000) Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human enterocyte-like Caco-2/TC-7 cells. Appl Environ Microbiol 66:1152-1157
19. Coconnier-Polter MH, Liévin-Le Moal V, Servin AL (2005) A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage. Appl Environ Microbiol 71:6115-6120
20. Collins SM, Bercik P (2009) The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136:2003-2014
21. Coron E et al (2009) Characterisation of early mucosal and neuronal lesions following Shigella flexneri infection in human colon. PLoS One 4:e4713
22. Cossart P, Toledo-Arana A (2008) Listeria monocytogenes, a unique model in infection biology: an overview. Microbes Infect 10:1041-1050
23. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R (2009) Bacterial community variation in human body habitats across space and time. Science 326(5960):1694-1697
24. Didierlaurent A, Sirard JC, Kraehenbuhl JP, Neutra MR (2002) How the gut senses its content. Cell Microbiol 4:61-72
25. Ewaschuk JB, Backer JL, Churchill TA, Obermeier F, Krause DO, Madsen KL (2007) Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun 75:2572-2579
26. Fagarasan S, Honjo T (2003) Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 3:63-72
27. Fagarasan S, Honjo T (2004) Regulation of IgA synthesis at mucosal surfaces. Curr Opin Immunol 16:277-283
28. Fantini J et al (1986) Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29. J Cell Sci 83:235-249
29. FAO/WHO (2001) Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Cordoba, Argentina, 1-4 Oct. 2001. ftp://ftp.fao.org/ docrep/fao/meeting/009/y6398e.pdf
30. FAO/WHO (2002) Guidelines for the evaluation of probiotics in food. Food and agriculture organization of the unites nations and world health organization working group report. ftp://ftp.fao.org/es/esn/food/wgreport2.pdf
31. Fogh J, Fogh JM, Orfeo T (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59:221-226
32. Franchi L, Warner N, Viani K, Nunez G (2009) Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 227:106-128
33. Freitas M, Cayuela C, Antoine JM, Piller F, Sapin C, Trugnan G (2001) A heat labile soluble factor from Bacteroides thetaiotaomicron VPI-5482 specifically increases the galactosylation pattern of HT29-MTX cells. Cell Microbiol 3:289-300
34. Freitas M, Tavan E, Cayuela C, Diop L, Sapin C, Trugnan G (2003) Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Biol Cell 95:503-506
35. Furrie E, Macfarlane S, Thomson G, Macfarlane GT (2005) Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 115:565-574
36. Ganz T (2001) Antimicrobial proteins and peptides in host defense. Semin Respir Infect 16:4-10
37. Garrett WS et al (2007) Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131:33-45
38. Gorbach SL (2000) Probiotics and gastrointestinal health. Am J Gastroenterol 95:S2-S4
39. Granato D et al (1999) Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells. Appl Environ Microbiol 65:1071-1077
40. Heuvelin E, Lebreton C, Grangette C, Pot B, Cerf-Bensussan N, Heyman M (2009) Mechanisms involved in alleviation of intestinal inflammation by Bifidobacterium breve soluble factors. PLoS One 4:e5184
41. Hooper LV, Xu J, Falk PG, Midtvedt T, Gordon JI (1999) A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U S A 96:9833-9838
42. Hooper LV, Falk PG, Gordon JI (2000) Analyzing the molecular foundations of commensalism in the mouse intestine. Curr Opin Microbiol 3:79-85
43. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291:881-884
44. Hooper LV, Midtvedt T, Gordon JI (2002) How host-microbial interactions shape the nutrient environment of the mammalian intestine. Ann Rev Nutr 22:283-307
45. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI (2003) Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4:269-273
46. Huang Y, Zheng Y (2009) The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells. Br J Nutr 103(4):473-478
47. Huet C, Sahuquillo-Merino C, Coudrier E, Louvard D (1987) Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. J Cell Biol 105:345-357
48. Imaoka A et al (2008) Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol 14:2511-2516
49. Johnson-Henry KC, Donato KA, Shen-Tu G, Gordanpour M, Sherman PM (2008) Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun 76:1340-1348
50. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2:123-140
51. Kelly D et al (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5:104-112
52. Kelly D, Conway S, Aminov R (2005) Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 26:326-333
53. Klingberg TD, Pedersen MH, Cencic A, Budde BB (2005) Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity. Appl Environ Microbiol 71:7528-7530
54. Ko JS, Yang HR, Chang JY, Seo JK (2007) Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-alpha. World J Gastroenterol 13:1962-1965
55. Koninkx JF, Malago JJ (2008) The protective potency of probiotic bacteria and their microbial products against enteric infections - review. Folia Microbiol 53:189-194
56. Korhonen R, Kosonen O, Korpela R, Moilanen E (2004) The expression of COX2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells. Lett Appl Microbiol 39:19-24
57. Kraehenbuhl JP, Neutra MR (2000) Epithelial M cells: differentiation and function. Ann Rev Cell Dev Biol 16:301-332
58. Kreusel KM, Fromm M, Schulzke JD, Hegel U (1991) Cl-secretion in epithelial monolayers of mucus-forming human colon cells (HT-29/B6). Am J Physiol 261:C574-C582
59. Laboisse C, Jarry A, Branka JE, Merlin D, Bou-Hanna C, Vallette G (1995) Regulation of mucin exocytosis from intestinal goblet cells. Biochem Soc Trans 23:810-813
60. Lammers KM et al (2002) Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol 97:1182-1186
61. Langefeld T, Mohamed W, Ghai R, Chakraborty T (2009) Toll-like receptors and NOD-like receptors: domain architecture and cellular signalling. Adv Exp Med Biol 653:48-57
62. Lebeer S, Vanderleyden J, De Keersmaecker SC (2008) Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev 72:728-764 (Table of Contents)
63. Lenoir C et al (2008) MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epithelial cells. Life Sci 82:519-528
64. Lesuffleur T et al (1991) Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 sub-populations selected for their commitment to differentiation. Int J Cancer 49:731-737
65. Ley RE et al (2008) Evolution of mammals and their gut microbes. Science 320:1647-1651
66. Liévin-Le Moal V, Amsellem R, Servin AL, Coconnier MH (2002) Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells. Gut 50:803-811
67. Liévin-Le Moal V, Servin AL (2006) The front line of enteric host defence against unwelcome intrusion of harmful microorganisms: mucins, antimicrobioal peptides and microbiota. Clin Microbiol Rev 19(2):315-337
68. Liévin-Le Moal V, Sarrazin-Davila LE, Servin AL (2007) An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhoea. Pediatrics 120:e795-e803
69. Lindfors K et al (2008) Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol 152:552-558
70. Liu TS et al (2003) Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunction. Am J Physiol Cell Physiol 284:C1073-C1082
71. Lopez-Boado YS, Wilson CL, Hooper LV, Gordon JI, Hultgren SJ, Parks WC (2000) Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J Cell Biol 148:1305-1315
72. Louvard D, Kedinger M, Hauri HP (1992) The differentiating intestinal epithelial cell: establishment and maintenance of functions through interactions between cellular structures. Ann Rev Cell Biol 8:157-195
73. Ma D, Forsythe P, Bienenstock J (2004) Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 72:5308-5314
74. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276:G941-G950
75. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA (2003) Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52:827-833
76. Madara JL, Stafford J, Dharmsathaphorn K, Carlson S (1987) Structural analysis of a human intestinal epithelial cell line. Gastroenterology 92:1133-1145
77. Mattar AF, Teitelbaum DH, Drongowski RA, Yongyi F, Harmon CM, Coran AG (2002) Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr Surg Int 18:586-590
78. Matter K, Balda MS (2003) Functional analysis of tight junctions. Methods 30:228-234
79. McCracken VJ, Lorenz RG (2001) The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 3:1-11
80. Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135-145
81. Menard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M (2004) Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53:821-828
82. Mercenier A, Pavan S, Pot B (2003) Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 9:175-191
83. Michail S, Abernathy F (2002) Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection. J Pediatr Gastroenterol Nutr 35:350-355
84. Michail S, Abernathy F (2003) Lactobacillus plantarum inhibits the intestinal epithelial migration of neutrophils induced by enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr 36:385-391
85. Mizoguchi A, Mizoguchi E (2008) Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol 43:1-17
86. Montalto M et al (2004) Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells. Digestion 69:225-228
87. Moorthy G, Murali MR, Devaraj SN (2009) Lactobacilli facilitate maintenance of intestinal membrane integrity during Shigella dysenteriae 1 infection in rats. Nutrition 25:350-358
88. Moriez R, Abdo H, Chaumette T, Faure M, Lardeux B, Neunlist M (2009) Neuroplasticity and neuroprotection in enteric neurons: role of epithelial cells. Biochem Biophys Res Commun 382:577-582
89. Nandakumar NS, Pugazhendhi S, Madhu Mohan K, Jayakanthan K, Ramakrishna BS (2009) Effect of Vibrio cholerae on chemokine gene expression in HT29 cells and its modulation by Lactobacillus GG. Scand J Immunol 69:181-187
90. Neudeck BL, Loeb JM, Faith NG (2004) Lactobacillus casei alters hPEPT1-mediated glycylsarcosine uptake in Caco-2 cells. J Nutr 134:1120-1123
91. Neunlist M et al (2003a) Toxin B of Clostridium difficile activates human VIP submucosal neurons, in part via an IL-1beta-dependent pathway. Am J Physiol Gastrointest Liver Physiol 285:G1049-G1055
92. Neunlist M et al (2003b) Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathways. Am J Physiol Gastrointest Liver Physiol 285:G1028-G1036
93. O'Hara AM et al (2006) Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118:202-215
94. Paolillo R, Romano Carratelli C, Sorrentino S, Mazzola N, Rizzo A (2009) Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. Int Immunopharmacol 9:1265-1271
95. Parassol N, Freitas M, Thoreux K, Dalmasso G, Bourdet-Sicard R, Rampal P (2005) Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol 156:256-262
96. Pasparakis M (2009) Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol 9:778-788
97. Patel JC, Galan JE (2005) Manipulation of the host actin cytoskeleton by Salmonella - all in the name of entry. Curr Opin Microbiol 8:10-15
98. Pedron T, Sansonetti P (2008) Commensals, bacterial pathogens and intestinal inflammation: an intriguing menage a trois. Cell Host Microbe 3:344-347
99. Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C (2005) Review article: bifidobacteria as probiotic agents - physiological effects and clinical benefits. Aliment Pharmacol Ther 22:495-512
100. Pinto M et al (1983) Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 47:323-330
101. Preidis GA, Versalovic J (2009) Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136:2015-2031
102. Putaala H et al (2008) Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Res Microbiol 159:692-698
103. Qin H, Zhang Z, Hang X, Jiang Y (2009) L. plantarum prevents enteroinvasive Escherichia coliinduced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol 9:63
104. Reid G, Bruce AW (2006) Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol 24:28-32
105. Resta-Lenert S, Barrett KE (2003) Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52:988-997
106. Resta-Lenert S, Barrett KE (2006) Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130:731-746
107. Riedel CU, Foata F, Philippe D, Adolfsson O, Eikmanns BJ, Blum S (2006) Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World J Gastroenterol 12:3729-3735
108. Ropeleski MJ, Tang J, Walsh-Reitz MM, Musch MW, Chang EB (2003) Interleukin-11-induced heat shock protein 25 confers intestinal epithelial-specific cytoprotection from oxidant stress. Gastroenterology 124:1358-1368
109. Roselli M, Finamore A, Britti MS, Mengheri E (2006) Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Br J Nutr 95:1177-1184
110. Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9:313-323
111. Rousseaux C et al (2007) Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 13:35-37
112. Rouyer-Fessard C, Augeron C, Grasset E, Maoret JJ, Laboisse CL, Laburthe M (1989) VIP receptors and control of short circuit current in the human intestinal clonal cell line Cl.19A. Experientia 45:1102-1105
113. Sanders ME, Hamilton J, Reid G, Gibson G (2007) A nonviable preparation of Lactobacillus acidophilus is not a probiotic. Clin Infect Dis 44:886
114. Sands BE (2007) Inflammatory bowel disease: past, present, and future. J Gastroenterol 42:16-25
115. Sansonetti PJ (2006) The bacterial weaponry: lessons from Shigella. Ann N Y Acad Sci 1072:307-312
116. Sansonetti PJ (2008) Host-bacteria homeostasis in the healthy and inflamed gut. Curr Opin Gastroenterol 24:435-439
117. Saxelin M, Tynkkynen S, Mattila-Sandholm T, de Vo s WM (2005) Probiotic and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol 16:204-211
118. Schiffrin EJ, Blum S (2002) Interactions between the microbiota and the intestinal mucosa. Eur J Clin Nutr 56(Suppl 3):S60-S64
119. Schlee M, Harder J, Koten B, Stange EF, Wehkamp J, Fellermann K (2008) Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol 151:528-535
120. Selsted ME, Ouellette AJ (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6:551-557
121. Servin AL (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28:405-440
122. Seth A, Yan F, Polk DB, Rao RK (2008) Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 294:G1060-G1069
123. Sherman PM, Johnson-Henry KC, Yeung HP, Ngo PS, Goulet J, Tompkins TA (2005) Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun 73:5183-5188
124. Sonnenburg JL, Chen CT, Gordon JI (2006) Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol 4:e413
125. Tao Y et al (2006) Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 290:C1018-C1030
126. Tien MT et al (2006) Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176:1228-1237
127. Toki S et al (2009) Lactobacillus rhamnosus GG and Lactobacillus casei suppress Escherichia coli-induced chemokine expression in intestinal epithelial cells. Int Arch Allergy Immunol 148:45-58
128. Torres AG, Zhou X, Kaper JB (2005) Adherence of diarrhoeagenic Escherichia coli strains to epithelial cells. Infect Immun 73:18-29
129. Turner JR (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9:799-809
130. Vanderpool C, Yan F, Polk DB (2008) Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 14:1585-1596
131. Van Landeghem L et al (2009) Regulation of intestinal epithelial cells transcriptome by enteric glial cells: impact on intestinal epithelial barrier functions. BMC Genomics 10:507
132. Vidal K, Donnet-Hughes A, Granato D (2002) Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect Immun 70:2057-2064
133. Viswanathan VK, Hodges K, Hecht G (2009) Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Nat Rev Microbiol 7:110-119
134. Vizoso Pinto MG, Schuster T, Briviba K, Watzl B, Holzapfel WH, Franz CM (2007) Adhesive and chemokine stimulatory properties of potentially probiotic Lactobacillus strains. J Food Prot 70:125-134
135. Vizoso Pinto MG, Rodriguez Gomez M, Seifert S, Watzl B, Holzapfel WH, Franz CM (2009) Lactobacilli stimulate the innate immune response and modulate the TLR expression of HT29 intestinal epithelial cells in vitro. Int J Food Microbiol 133:86-93
136. 2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa. Gastroenterology 135:1216-1227
137. Wallace TD, Bradley S, Buckley ND, Green-Johnson JM (2003) Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production. J Food Prot 66:466-472
138. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427-434
139. Xu J et al (2003) A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299:2074-2076
140. Xu J et al (2007) Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol 5:e156
141. Yan F, Polk DB (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277:50959-50965
142. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132:562-575
143. Zocco MA, Ainora ME, Gasbarrini G, Gasbarrini A (2007) Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. Dig Liver Dis 39:707-712
144. Zweibaum A et al (1985) Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 122:21-29
145. Zweibaum A, Laburthe M, Grasset E, Louvard D (1991) Use of cultured cell lines in studies of intestinal cell differentiation and function. In: Schultz SJ, Field FM, Frizell RA (eds) Handbook of physiology, the gastrointestinal system, intestinal absorption and secretion. American Physiological Society, Bethesda, pp 223-255